Annual Operating Expenses
$24.86 M
-$2.92 M-10.50%
December 31, 2023
Summary
- As of February 7, 2025, MTNB annual total operating expenses is $24.86 million, with the most recent change of -$2.92 million (-10.50%) on December 31, 2023.
- During the last 3 years, MTNB annual operating expenses has risen by +$497.10 thousand (+2.04%).
- MTNB annual operating expenses is now -10.50% below its all-time high of $27.78 million, reached on December 31, 2022.
Performance
MTNB Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$4.38 M
-$1.46 M-24.97%
September 30, 2024
Summary
- As of February 7, 2025, MTNB quarterly total operating expenses is $4.38 million, with the most recent change of -$1.46 million (-24.97%) on September 30, 2024.
- Over the past year, MTNB quarterly operating expenses has dropped by -$1.75 million (-28.58%).
- MTNB quarterly operating expenses is now -43.27% below its all-time high of $7.72 million, reached on March 31, 2022.
Performance
MTNB Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
MTNB Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.5% | -28.6% |
| 3 y3 years | +2.0% | -28.6% |
| 5 y5 years | +68.4% | -28.6% |
MTNB Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.5% | +0.4% | -43.3% | at low |
| 5 y | 5-year | -10.5% | +30.8% | -43.3% | at low |
| alltime | all time | -10.5% | +569.7% | -43.3% | +3808.1% |
Matinas BioPharma Holdings Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.38 M(-25.0%) |
| Jun 2024 | - | $5.84 M(-1.1%) |
| Mar 2024 | - | $5.90 M(+0.3%) |
| Dec 2023 | $24.86 M(-10.5%) | $5.89 M(-4.0%) |
| Sep 2023 | - | $6.13 M(-0.4%) |
| Jun 2023 | - | $6.16 M(-7.8%) |
| Mar 2023 | - | $6.68 M(+2.1%) |
| Dec 2022 | $27.78 M(+12.2%) | $6.54 M(+0.3%) |
| Sep 2022 | - | $6.53 M(-6.6%) |
| Jun 2022 | - | $6.99 M(-9.5%) |
| Mar 2022 | - | $7.72 M(+15.0%) |
| Dec 2021 | $24.77 M(+1.7%) | $6.71 M(-2.4%) |
| Sep 2021 | - | $6.88 M(+43.6%) |
| Jun 2021 | - | $4.79 M(-25.0%) |
| Mar 2021 | - | $6.39 M(-2.5%) |
| Dec 2020 | $24.36 M(+28.2%) | $6.55 M(+14.9%) |
| Sep 2020 | - | $5.70 M(-1.1%) |
| Jun 2020 | - | $5.77 M(-9.1%) |
| Mar 2020 | - | $6.35 M(+10.6%) |
| Dec 2019 | $19.01 M(+28.7%) | $5.74 M(+25.8%) |
| Sep 2019 | - | $4.56 M(-1.1%) |
| Jun 2019 | - | $4.61 M(+12.4%) |
| Mar 2019 | - | $4.10 M(-1.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $14.77 M(-11.3%) | $4.17 M(+41.0%) |
| Sep 2018 | - | $2.95 M(-15.5%) |
| Jun 2018 | - | $3.49 M(-15.8%) |
| Mar 2018 | - | $4.15 M(-11.2%) |
| Dec 2017 | $16.65 M(+101.7%) | $4.68 M(+35.4%) |
| Sep 2017 | - | $3.45 M(-14.1%) |
| Jun 2017 | - | $4.02 M(-10.7%) |
| Mar 2017 | - | $4.50 M(+75.6%) |
| Dec 2016 | $8.26 M(-18.3%) | $2.56 M(+39.7%) |
| Sep 2016 | - | $1.84 M(+13.3%) |
| Jun 2016 | - | $1.62 M(-27.6%) |
| Mar 2016 | - | $2.24 M(-19.6%) |
| Dec 2015 | $10.11 M(-3.4%) | $2.78 M(+25.4%) |
| Sep 2015 | - | $2.22 M(-10.5%) |
| Jun 2015 | - | $2.48 M(-5.6%) |
| Mar 2015 | - | $2.63 M(-20.7%) |
| Dec 2014 | $10.46 M(+181.9%) | $3.31 M(+27.1%) |
| Sep 2014 | - | $2.61 M(+7.6%) |
| Jun 2014 | - | $2.42 M(+13.7%) |
| Mar 2014 | - | $2.13 M(+18.0%) |
| Dec 2013 | $3.71 M | $1.80 M(+24.1%) |
| Sep 2013 | - | $1.45 M(+323.2%) |
| Jun 2013 | - | $343.40 K(+206.3%) |
| Mar 2013 | - | $112.10 K |
FAQ
- What is Matinas BioPharma Holdings annual total operating expenses?
- What is the all time high annual operating expenses for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual operating expenses year-on-year change?
- What is Matinas BioPharma Holdings quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly operating expenses year-on-year change?
What is Matinas BioPharma Holdings annual total operating expenses?
The current annual operating expenses of MTNB is $24.86 M
What is the all time high annual operating expenses for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual total operating expenses is $27.78 M
What is Matinas BioPharma Holdings annual operating expenses year-on-year change?
Over the past year, MTNB annual total operating expenses has changed by -$2.92 M (-10.50%)
What is Matinas BioPharma Holdings quarterly total operating expenses?
The current quarterly operating expenses of MTNB is $4.38 M
What is the all time high quarterly operating expenses for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly total operating expenses is $7.72 M
What is Matinas BioPharma Holdings quarterly operating expenses year-on-year change?
Over the past year, MTNB quarterly total operating expenses has changed by -$1.75 M (-28.58%)